Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued to investors on Friday, Benzinga reports. They presently have a $105.00 target price on the stock. HC Wainwright’s target price would indicate a potential upside of 98.56% from the company’s previous […]
Praxis Precision Medicines (NASDAQ:PRAX) Sees Strong Trading Volume theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 6 1% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) traded down 6.1% on Wednesday . The company traded as low as $51.82 and last traded at $52.18. 81,782 shares changed hands during mid-day trading, a decline of 62% from the average session volume of 213,917 shares. The stock had previously closed at $55.57. […]